Literature DB >> 17181603

Behavioural equivalents of anxiety in children with fragile X syndrome: parent and teacher report.

Kelly Sullivan1, Stephen Hooper, Deborah Hatton.   

Abstract

BACKGROUND: Identifying many of the diagnostic criteria for anxiety and depression in individuals with intellectual disability (ID) can be challenging because they may be unable to recognize and communicate their emotional experiences accurately. The purpose of this study is to identify behavioural equivalents of anxiety in children with fragile X syndrome (FXS), the leading inherited cause of ID.
METHODS: Parents and teachers of 43 children (aged 6-14 years) with full mutation FXS completed two standardized questionnaires on children's problem behaviour and psychiatric symptoms. Items from the questionnaires thought to be possible behavioural equivalents of anxiety were identified and grouped into four domains: Avoidance Behaviours - Confrontational; Avoidance Behaviours - Non-confrontational; Anxiety Continuum Behaviours; and Behavioural Dysregulation. The mean rating for the four groups of items was used to predict the children's status for exhibiting significant problems with anxiety as defined by the Diagnostic and Statistical Manual of Mental Disorders-oriented Anxiety Subscale from the problem behaviour scale.
RESULTS: The predictor variables classified 81% (parent rating) and 86% (teacher rating) of the children correctly. Avoidance Behaviours - Confrontational and Avoidance Behaviours - Non-confrontational (teacher rating) and Anxiety Continuum Behaviours (parent and teacher rating) made unique contributions to the models.
CONCLUSIONS: Children who are unable to identify and communicate that they worry about general day-to-day events may exhibit more observable behaviours resembling active and passive avoidance (e.g. arguing, avoiding difficult tasks, staring off) or have specific phobias and compulsions. These findings suggest that there are behavioural equivalents for anxiety disorder in children with FXS and, more generally, support the notion of behavioural equivalents in ID.

Entities:  

Mesh:

Year:  2007        PMID: 17181603     DOI: 10.1111/j.1365-2788.2006.00899.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  11 in total

1.  Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures.

Authors:  Agustini Utari; Weerasak Chonchaiya; Susan M Rivera; Andrea Schneider; Randi J Hagerman; Sultana M H Faradz; Iryna M Ethell; Danh V Nguyen
Journal:  Am J Intellect Dev Disabil       Date:  2010-09

Review 2.  Public Health Literature Review of Fragile X Syndrome.

Authors:  Melissa Raspa; Anne C Wheeler; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

Review 3.  Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.

Authors:  Christina Gross; Elizabeth M Berry-Kravis; Gary J Bassell
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

4.  Early negative affect predicts anxiety, not autism, in preschool boys with fragile X syndrome.

Authors:  Bridgette L Tonnsen; Patrick S Malone; Deborah D Hatton; Jane E Roberts
Journal:  J Abnorm Child Psychol       Date:  2013-02

5.  Insular volume reduction in fragile X syndrome.

Authors:  Jeremy D Cohen; Taylor Nichols; Laura Brignone; Scott S Hall; Allan L Reiss
Journal:  Int J Dev Neurosci       Date:  2011-02-01       Impact factor: 2.457

6.  Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation.

Authors:  R Nick Hernandez; Rachel L Feinberg; Rebecca Vaurio; Natalie M Passanante; Richard E Thompson; Walter E Kaufmann
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

Review 7.  The cyclic AMP phenotype of fragile X and autism.

Authors:  Daniel J Kelley; Anita Bhattacharyya; Garet P Lahvis; Jerry C P Yin; Jim Malter; Richard J Davidson
Journal:  Neurosci Biobehav Rev       Date:  2008-06-17       Impact factor: 8.989

8.  Targeted treatments for fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; Andrew Knox; Crystal Hervey
Journal:  J Neurodev Disord       Date:  2011-02-19       Impact factor: 4.025

9.  Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome.

Authors:  David Hessl; Danielle Harvey; Stephanie Sansone; Crystal Crestodina; Jamie Chin; Reshma Joshi; Randi J Hagerman; Elizabeth Berry-Kravis
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

10.  A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.

Authors:  E Berry-Kravis; D Hessl; S Coffey; C Hervey; A Schneider; J Yuhas; J Hutchison; M Snape; M Tranfaglia; D V Nguyen; R Hagerman
Journal:  J Med Genet       Date:  2009-01-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.